Patrick Colin

Professor at Universite de Montreal - Canada

Patrick Colin

Patrick Colin

Professor at Universite de Montreal - Canada

Overview
Career Highlights

gicare Pharma, Inc.

RelSci Relationships

133

Relationships
RelSci Relationships are individuals Patrick Colin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Professor at Universite de Montreal - Canada

Relationship likelihood: Strong

Co-Founder at Verlyx Pharma, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Verlyx Pharma, Inc.

Relationship likelihood: Strong

Operations Director at Verlyx Pharma, Inc.

Relationship likelihood: Strong

Co-Founder at 9342-8530 Québec, Inc.

Relationship likelihood: Strong

Director, Center for Optics, Photonics & Lasers at Laval University

Relationship likelihood: Strong

Associate Dean at Laval University

Relationship likelihood: Strong

Professor at Laval University

Relationship likelihood: Strong

Founder & Chief Technology Officer at LensVector, Inc.

Relationship likelihood: Strong

Chief Financial Officer at Whatsnexx Marketing Automation, Inc.

Relationship likelihood: Average

Paths to Patrick Colin
Potential Connections via
Relationship Science
You
Patrick Colin
Professor at Universite de Montreal - Canada
Education

The Université de Montréal is a public research university in Montreal, Quebec, Canada. The francophone institution comprises thirteen faculties, more than sixty departments and two affiliated schools: the École Polytechnique (School of Engineering) and HEC Montréal (School of Business). It offers more than 650 undergraduate programmes and graduate programmes.

Memberships

Quebec Order of Pharmacists operates association for pharmacists. It recognizes the public''s right to information and favors transparent and proactive communication, imbued with the values of humanism and integrity. The company is headquartered in Montreal, Canada.

Career History
Chief Development Officer & Senior Vice President
2011 - Current

Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada.

Professor
Current

The Université de Montréal is a public research university in Montreal, Quebec, Canada. The francophone institution comprises thirteen faculties, more than sixty departments and two affiliated schools: the École Polytechnique (School of Engineering) and HEC Montréal (School of Business). It offers more than 650 undergraduate programmes and graduate programmes.

Professor
Current

The oldest centre of education in Canada, and was the first institution in North America to offer higher education in French.

Investments
Details Hidden

gIcare Pharma, Inc. develops gastrointestinal drugs. It develops orally-administered drug GIC-1001 which provides colonic analgesia. The company was founded by Patrick Colin and Maxime Ranger in 2011 and is headquartered in Montreal, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Patrick Colin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Patrick Colin's profile does not indicate a business or promotional relationship of any kind between RelSci and Patrick Colin.